Guardant Health Receives European Approval Of Guardant360 CDx As Companion Diagnostic For AstraZeneca’s ETCAMAH
Benzinga Newsdesk 3 weeks ago
NewsBiotechGeneral
Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global geographiesThis latest approval marks Guardant’s 31st CDx approval
- Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global geographies
- This latest approval marks Guardant’s 31st CDx approval